Important Notice for LifeMD Inc. Shareholders: Act Before October 2025 Deadline

Important Notice to LifeMD, Inc. Investors



On September 15, 2025, The Gross Law Firm announced critical information for shareholders of LifeMD, Inc. (NASDAQ: LFMD). Investors who purchased shares during the specified class period from May 7, 2025, to August 5, 2025, are encouraged to reach out to the firm for discussions regarding their potential rights and participation in class-action litigation.

What is the Class Period?


The defined class period signifies the time frame during which investors may have incurred losses due to misleading statements by the company. Specifically, shareholders who bought shares of LifeMD within this period should take immediate action to safeguard their rights.

Allegations Against LifeMD


The complaint highlights serious concerns regarding LifeMD's operations during the class period. Allegations suggest that the company’s defendants issued materially false and misleading statements, endangering shareholders' investments. Specific claims include:
1. Overstated Competitive Position: LifeMD allegedly exaggerated its competitive position within the industry.
2. Reckless Financial Guidance: The company raised its financial guidance for 2025 without adequately considering rising customer acquisition costs, particularly within its RexMD segment and costs associated with the sale of obesity-related drugs like Wegovy and Zepbound.
3. False Business Assertions: As a result, statements made by the defendants about LifeMD's overall business performance, operational health, and growth prospects were deemed misleading and lacked a reasonable basis.

Class Action Participation and Next Steps


The deadline for investors to register as lead plaintiffs is October 25, 2025. Interested shareholders should not wait to assert their rights. Once registered, participants will be enrolled in a portfolio monitoring system, which will provide updates on the case as it progresses. Shareholders can register their information through the provided link.

Why Choose The Gross Law Firm?


The Gross Law Firm is a nationally recognized entity specializing in class action litigation. Their team focuses on protecting the rights of investors against corporate misconduct and fraudulent business practices. The firm is dedicated to ensuring that companies operate responsibly and adhere to high standards of corporate citizenship.

In the event of successful litigation, the firm seeks recovery for investors who have suffered losses due to misleading information affecting stock prices. Importantly, there is no cost or obligation for shareholders to participate in this case.

Contact Information


For more information, LifeMD investors can contact The Gross Law Firm directly at:
  • - Address: 15 West 38th Street, 12th Floor, New York, NY 10018
  • - Email: [email protected]
  • - Phone: (646) 453-8903

In summary, it is imperative for shareholders of LifeMD, Inc. to act swiftly and consult with The Gross Law Firm ahead of the October 25, 2025 deadline. Ensure that your rights are protected and that you are informed about the potential for recovery in this active class action.

  • ---

Topics Financial Services & Investing)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.